| Martin Babler | President, Chief Executive Officer, and Chairman of the Board | FY2025 | |
| David M. Goldstein, Ph.D. | Chief Scientific Officer | FY2025 | |
| Jörn Drappa, M.D., Ph.D. | Chief Medical Officer | FY2025 |
3 executives
Named executives and their total pay come from the Summary Compensation Table of the latest proxy statement.